摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4-ClC6H4)3SbBr2 | 91002-41-4

中文名称
——
中文别名
——
英文名称
(4-ClC6H4)3SbBr2
英文别名
dibromo-tris(4-chlorophenyl)-λ5-stibane
(4-ClC6H4)3SbBr2化学式
CAS
91002-41-4
化学式
C18H12Br2Cl3Sb
mdl
——
分子量
616.21
InChiKey
LLMDVARJKORQPE-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.85
  • 重原子数:
    24.0
  • 可旋转键数:
    3.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    0.0
  • 氢给体数:
    0.0
  • 氢受体数:
    0.0

反应信息

  • 作为反应物:
    描述:
    (4-ClC6H4)3SbBr2邻苯二甲酰亚胺钠盐 生成 2-[tris(4-chlorophenyl)-(1,3-dioxoisoindol-2-yl)-λ5-stibanyl]isoindole-1,3-dione
    参考文献:
    名称:
    SINGHAL, KIRAN;RASTOGI, RAJIV;RAJ, PREM, INDIAN J. CHEM., 26,(1987) N 2, 146-150
    摘要:
    DOI:
  • 作为产物:
    描述:
    氯(4-氯苯基)镁乙醚乙醇 为溶剂, 生成 (4-ClC6H4)3SbBr2
    参考文献:
    名称:
    Gmelin Handbuch der Anorganischen Chemie, Gmelin Handbook: Sb: Org.Comp.1, 1.1.1.1.7, page 87 - 96
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Synthesis, characterization and in vitro antitumor activity of some arylantimony ferrocenylcarboxylate derivatives and the crystal structures of [C5H5FeC5H4C(CH3)CHCOO]2Sb(C6H4F-4)3 and [4-(C5H5FeC5H4)C6H4COO]2Sb(C6H4F-4)3
    作者:Lin Yu、Yong-Qiang Ma、Run-Chang Liu、Guo-Cang Wang、Jin-Shan Li、Guan-Hua Du、Juan-Juan Hu
    DOI:10.1016/j.poly.2003.12.002
    日期:2004.3
    A series of novel arylantimony ferrocenylcarboxylate derivatives with the formulae [C5H5FeC5H4C(CH3)=CHCOO](2)SbAr3 and [4-(C5H5FeC5H4)C6H4COO](2)SbAr3 (Ar=C6H5, 4-CH3C6H4, 4-ClC6H4, 4-FC6H4) were synthesized and characterized by elemental analysis, IR and H-1 NMR. The crystal structures of [C5H5FeC5H4C(CH3)=CHCOO](2)Sb(C6H4F-4)(3) and [4-(C5H5FeC5H4)C6H4COO](2)Sb(C6H4F-4)(3) were determined by X-ray diffraction. The two sets of crystal X-ray data show that the antimony atom of the former has a special six-coordinate geometry while that of the latter has a general five-coordinate geometry. Three human neoplastic cell lines (HCT-8, Bel-7402 and KB) were used to screen these compounds. The results indicate that [C5H5FeC5H4C(CH3)=CHCO2](2)Sb(C6H4Cl-4)(3) and [C5H5FeC5H4C(CH3)=CHCO2](2)Sb(C6H4F-4)(3) at 5 muM show relatively good in vitro antitumor activities. (C) 2003 Elsevier Ltd. All rights reserved.
  • Synthesis, crystal structures and in vitro antitumor activities of some arylantimony derivatives of analogues of demethylcantharimide
    作者:Guo-Cang Wang、Jian Xiao、Lin Yu、Jin-Shan Li、Jing-Rong Cui、Rui-Qing Wang、Fu-Xiang Ran
    DOI:10.1016/j.jorganchem.2004.02.015
    日期:2004.5
    A series of novel aylantimony derivatives of analogues of demethylcantharimide with the formulae ArnSbL(5-n) and ArnSbL'((5-n))(LH = N-hydroxy-demethyldehydrogencantharimide, L'H = N-hydroxy-demethyleantharimide, n = 3, 4; Ar=C6H5, 4CH(3)C(6)H(4), 3-CH3C6H4, 2-CH3C6H4, 4-ClC6H4, 4-FC6H4) were synthesized and characterized by elemental analysis, IR, 1 H NMR and mass spectroscopy. The crystal structures of (C6H5)(4)SbL, (4-CH3C6H4)(3)SbL2 and (3-CHC6H4)(3)SbL'(2) were determined by X-ray diffraction. The in vitro antitumor activities of all compounds against six cancer cells are reported. (C) 2004 Elsevier B.V. All rights reserved.
  • Synthesis, characterization and antitumor activity of some arylantimony triphenylgermanylpropionates and crystal structures of Ph3GeCH(Ph)CH2CO2SbPh4 and [Ph3GeCH2CH(CH3)CO2]2Sb(4-ClC6H4)3
    作者:Yongqiang Ma、Jinshan Li、Zhenai Xuan、Runchang Liu
    DOI:10.1016/s0022-328x(00)00799-3
    日期:2001.2
    A series of novel arylantimony(V) triphenylgermanylpropionates with the formula ((Ph3GeCHRCHRCO2)-C-1-C-2)(n)SbAr(5-n) (R-1 = H, Ph; R-2 =H, CH3; n = 1, 2) were synthesized and characterized by elemental analysis, IR, H-1-NMR, C-13-NMR and mass spectroscopy. The crystal structures of Ph3GeCH(Ph)CH2CO2SbPh4 and [Ph3GeCH2CH(CH3)CO2](2)Sb(4-ClC6H4)(3) were determined by X-ray diffraction. The in vitro antitumor activities of some selected compounds against five cancer cells are reported. (C) 2001 Elsevier Science B.V. All rights reserved.
  • Synthesis, crystal structures and in vitro antitumor activities of some organoantimony arylhydroxamates
    作者:Guo-Cang Wang、Yong-Na Lu、Jian Xiao、Lin Yu、Hai-Bin Song、Jin-Shan Li、Jing-Rong Cui、Rui-Qing Wang、Fu-Xiang Ran
    DOI:10.1016/j.jorganchem.2004.09.002
    日期:2005.1
    A series of novel organoantimony arylhydroxamates with the formulae [Ar3SbL2,](-)[HNEt3](+) (LH = arylhydroxamic acid: Ar = C6H5. 4-CH3C6H4, 3-CH3C6H4, 4-ClC6H4, 4-FC6H4) and (4-CH3C6H4)(4)SbL were synthesized and characterized by elemental analysis, IR. H-1 NMR and mass spectroscopy. The crystal structures of (4-CH3C6H4)(4)SbL and [Ph3SbL2](-)[HNEt3](+) were determined by X-ray diffraction. The in vitro antitumor activities of all compounds against three human cancer cells are reported. (C) 2004 Published by Elsevier B.V..
  • Harris, J. I.; Bowden, S. T.; Jones, W. J., Journal of the Chemical Society
    作者:Harris, J. I.、Bowden, S. T.、Jones, W. J.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫